IVVD · NASDAQ
Invivyd (IVVD) Stock Price & Fundamentals
Invivyd (IVVD) closed at $775.67 on Oct 9, 2026, down 0.32% from the previous close of $778.15.
Share price, past year
1Y +29.25%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $775.67 |
| Sep 30, 2026 | $785.87 |
| Aug 31, 2026 | $728.23 |
| Jul 31, 2026 | $748.31 |
| Jun 30, 2026 | $698.07 |
| May 29, 2026 | $641.31 |
| Apr 30, 2026 | $655.92 |
| Mar 31, 2026 | $699.55 |
| Feb 27, 2026 | $648.82 |
| Jan 30, 2026 | $618.15 |
| Dec 31, 2025 | $597.97 |
| Nov 28, 2025 | $619.76 |
| Oct 31, 2025 | $636.00 |
Key statistics
- Market cap
- $228.63B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.31
- Revenue (TTM)
- $58.37M
- Net income (TTM)
- −$107.33M
- Shares outstanding
- 294.8M
- Dividend yield
- —
- 52-week range
- $578.49 – $797.55
Invivyd's market cap is $228.63B, based on a share price of $775.67 and 294.8M shares outstanding as of Jun 30, 2026.
Financials
Invivyd reported revenue of $53.43M for fiscal 2025, up 110.47% from fiscal 2024.
Invivyd reported a net loss of $52.49M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $53.43M | +110.5% | −$52.49M | −98.3% | −$0.30 | −$58.29M |
| FY2024ended Dec 31, 2024 | $25.38M | — | −$169.93M | −669.4% | −$1.43 | −$170.63M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$198.64M | — | −$1.81 | −$173.78M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $14.29M | −$44.39M | −$0.14 |
| Q1 FY2026ended Mar 31, 2026 | $13.74M | −$41.40M | −$0.13 |
| Q4 FY2025ended Dec 31, 2025 | $17.21M | −$11.07M | $0.02 |
| Q3 FY2025ended Sep 30, 2025 | $13.13M | −$10.47M | −$0.06 |
| Q2 FY2025ended Jun 30, 2025 | $11.79M | −$14.66M | −$0.12 |
| Q1 FY2025ended Mar 31, 2025 | $11.30M | −$16.29M | −$0.14 |
| Q4 FY2024ended Dec 31, 2024 | $13.82M | −$18.44M | −$0.14 |
| Q3 FY2024ended Sep 30, 2024 | $9.30M | −$60.74M | −$0.51 |
Company profile
- Name
- Invivyd, Inc.
- Ticker
- IVVD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 205 Church Street, New Haven, CT
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001832038
Recent SEC filings
- Sep 29, 2026
- Sep 1, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jul 24, 2026
- Jul 6, 2026
- May 19, 2026
- May 14, 2026
Frequently asked questions
What is Invivyd's stock price?
Invivyd (IVVD) closed at $775.67 on Oct 9, 2026, down 0.32% from the previous close of $778.15.
What is Invivyd's market cap?
Invivyd's market cap is $228.63B, based on a share price of $775.67 and 294.8M shares outstanding as of Jun 30, 2026.
How much revenue does Invivyd make?
Invivyd reported revenue of $53.43M for fiscal 2025, up 110.47% from fiscal 2024.
Does Invivyd pay a dividend?
Invivyd's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Invivyd, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures